SEC Form 4 · accession 0001070081-17-000096
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marcio Souza
Officer — Chief Operating Officer
Period of report
May 31, 2017
Accepted (ET)
Jun 2, 2017 · 6:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 31, 2017 | A | 30,000 | $0.00 | A | 36,457 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right To Buy)F2 | $12.53 | May 31, 2017 | A | 30,000 | A | — | May 31, 2017 | Common Stock | 30,000 | 30,000 | D |
| Stock Option (Right To Buy)F3 | $26.42 | holding | — | — | — | — | Jul 31, 2024 | Common Stock | 30,000 | 30,000 | D |
| Stock Option (Right To Buy)F4 | $51.00 | holding | — | — | — | — | Jan 2, 2025 | Common Stock | 10,525 | 10,525 | D |
| Stock Option (Right To Buy)F5 | $30.86 | holding | — | — | — | — | Jan 3, 2026 | Common Stock | 16,000 | 16,000 | D |
| Stock Option (Right To Buy)F6 | $12.64 | holding | — | — | — | — | Nov 16, 2026 | Common Stock | 2,000 | 2,000 | D |
| Stock Option (Right To Buy)F7 | $11.23 | holding | — | — | — | — | Jan 2, 2027 | Common Stock | 23,100 | 23,100 | D |
| Stock Option (Right To Buy)F8 | $12.92 | holding | — | — | — | — | May 17, 2027 | Common Stock | 10,000 | 10,000 | I |
Explanation of responses
- F1Restricted stock awarded to the Reporting Person vests in two equal annual installments over two years, commencing on May 31, 2018.
- F2This option was granted on May 31, 2017, and vests in two equal annual installments over two years, commencing on May 31, 2018.
- F3This option was granted on July 31, 2014 and vests over four years, with 25% of the shares underlying the option vested on July 31, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on October 31, 2015.
- F4This option was granted on January 2, 2015 and vests over four years, with 25% of the shares underlying the option vested on January 2, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 2, 2016.
- F5This option was granted on January 4, 2016 and vests over four years, with 25% of the shares underlying the option vested on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.
- F6This option was granted on November 17, 2016, and vests over four years, with 25% of the shares underlying the option vesting on November 17, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on February 17, 2018.
- F7This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.
- F8This option was granted on May 17, 2017, and vests over four years, with 25% of the shares underlying the option vesting on May 8, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on August 8, 2018.